Showing results (461-470 of 570) with videos related to
Sort By:
Pageof 57
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of actionA M Malfait, A S Malik, L Marinova-Mutafchieva, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinasesA D Foey, S L Parry, L M Williams, et al.Clinical and Experimental Immunology|March 5, 1998
Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritisA M Malfait, D M Butler, D H Presky, et al.Immunology|January 1, 1995
Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNFA P Cope, D Aderka, D Wallach, et al.Arthritis and Rheumatism|March 1, 1996
Interleukin-10 inhibition of the progression of established collagen-induced arthritisM Walmsley, P D Katsikis, E Abney, et al.Clinical and Experimental Immunology|December 1, 1987
Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patientsV L Calder, A S Bellamy, S Owen, et al.Brain : a Journal of Neurology|August 19, 2007
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosisA Lockhart, J R Lamb, T Osredkar, et al.International Immunology|January 1, 1989
Stress proteins may provide a link between the immune response to infection and autoimmunityJ R Lamb, V Bal, P Mendez-Samperio, et al.Arthritis and Rheumatism|October 1, 1992
Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alphaB W Deleuran, C Q Chu, M Field, et al.The Journal of Experimental Medicine|January 1, 1992
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogeneM R Shalaby, H M Shepard, L Presta, et al.Pageof 57